Disease-associated regulation of gene expression by resveratrol: Special focus on the PI3K/AKT signaling pathway

S Ghafouri-Fard, Z Bahroudi, H Shoorei… - Cancer Cell …, 2022 - Springer
Abstract Resveratrol (3, 5, 4′-trihydroxy-trans-stilbene) is a natural phenol that is present in
the skin of the grape, blueberry, raspberry, mulberry, and peanut. This substance is …

Molecular targeting of the BRAF proto-oncogene/mitogen-activated protein kinase (MAPK) pathway across cancers

KS Shan, TU Rehman, S Ivanov, G Domingo… - International Journal of …, 2024 - mdpi.com
The mitogen-activated protein kinase (MAPK) pathway is essential for cellular proliferation,
growth, and survival. Constitutive activation of this pathway by BRAF mutations can cause …

Molecular basis of resveratrol-induced resensitization of acquired drug-resistant cancer cells

CY Choi, SC Lim, TB Lee, SI Han - Nutrients, 2022 - mdpi.com
Multidrug resistance (MDR) to anticancer drugs remains a serious obstacle to the success of
cancer chemotherapy. Resveratrol, a polyphenol, present in natural products exerts …

Resensitization of Akt Induced Docetaxel Resistance in Breast Cancer by 'Iturin A' a Lipopeptide Molecule from Marine Bacteria Bacillus megaterium

G Dey, R Bharti, AK Das, R Sen, M Mandal - Scientific reports, 2017 - nature.com
Abstract Development of the resistance is the major problem in cancer therapy. Docetaxel is
a taxol alkaloid that is frequently used in metastatic breast cancer. However, resistance often …

Current report of natural product development against breast cancer stem cells

A Hermawan, H Putri - The international journal of biochemistry & cell …, 2018 - Elsevier
Chemotherapeutic agents are commonly used as neoadjuvant for breast cancer therapy.
However, there is evidence of treatment failure for most of patients due to acquired …

The mechanism and consequences of BRAF inhibitor resistance in melanoma

K Golub, W Bai, Z Zhang, H Xiao, R Sun, J Shen… - Genome Instability & …, 2023 - Springer
Abstract BRAF V600E is a constitutive BRAF (B-raf proto-oncogene, serine/threonine
kinase) mutation that accounts for more than 90% of BRAF mutations in melanoma …

Melanoma chemoprevention: Current status and future prospects

G Chhabra, MA Ndiaye… - Photochemistry and …, 2017 - Wiley Online Library
The incidence of skin cancers, both nonmelanoma and melanoma, is increasing in the
United States. The ultraviolet radiation, mainly from sun, is considered the major cause for …

[HTML][HTML] T-type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAFV600E melanoma

C Barceló, P Sisó, O Maiques, S Garcia-Mulero… - Journal of Investigative …, 2020 - Elsevier
Melanoma is a malignant neoplasia that is highly resistant to chemotherapy and
radiotherapy and is associated with poor prognosis in advanced stage. Targeting melanoma …

Unraveling the molecular mechanisms and the potential chemopreventive/therapeutic properties of natural compounds in melanoma

F Fontana, M Raimondi, A Di Domizio… - Seminars in Cancer …, 2019 - Elsevier
Melanoma is the most fatal form of skin cancer. Current therapeutic approaches include
surgical resection, chemotherapy, targeted therapy and immunotherapy. However, these …

The dual PI3K/mToR inhibitor omipalisib/GSK2126458 inhibits clonogenic growth in oncogenically-transformed cells from neurocutaneous melanocytosis

D Basu, CM Salgado, B Bauer, Y Khakoo… - Cancer Genomics & …, 2018 - cgp.iiarjournals.org
Background: Omipalisib has been found to affect the viability of cancer cells. However, its
effect on clonogenicity–a feature of cancer stem cells, is not clear. Cells isolated from …